Events By Category | Events By Hotbed | Event News | Search Events
Event NameTCT 2017
Event Date(s) Sunday, October 29, 2017  to Thursday, November 02, 2017
Event Location TBA
Denver, Colorado
U.S.A.
Cost$0 - $1,949
DescriptionTranscatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation translates into improved patient care.

ACCME

Target Audience

This symposium is designed for interventional cardiologists, radiologists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals with a special interest in the field of interventional and vascular medicine.

Needs Statement

TCT provides the latest evidence-based data, presented by leading physicians, nurses, and scientists, that will affect the practice of interventional cardiology and endovascular medicine. TCT showcases the practical applications of current and emerging techniques and technologies and an unparalleled diversity of Live Case presentations from universities and medical centers from around the world. In the field of interventional cardiology, only TCT combines the late-breaking science and practical education that physicians need to improve patient outcomes. Activity Goals The overall goal of this activity is to improve the competence and performance of our target audience by delivering cutting-edge educational content that showcases the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation will translate into improved patient care.

Learning Objectives

By the end of the symposium, participants should be able to:

• Apply the results from important clinical trials and evidence-based medicine to guide the management of patients with atherosclerosis and structural heart disease
• Incorporate new interventional technologies and procedures into the care of patients with complex coronary and endovascular disease
• Integrate advances in diagnostic evaluation and therapeutics into the treatment of patients with carotid and peripheral arterial disease
• Implement appropriate pharmacologic management in the care of patients undergoing diagnostic arteriography and interventional therapies before, during, and after catheterization
• Identify new interventional technologies and propose appropriate applications for patients with cardiovascular disease
SponsorRebound Therapeutics
Host CompanyRebound Therapeutics
Contact Information Phone: 646-434-4394
Fax:   646-434-4713 
Email: jware@crf.org
More Information http://www.crf.org/tct
 
//-->